Sales & Marketing Views & Analysis

Views & Analysis

Sales & Marketing

Interview at JPM26 with Helen Sabzevari and Greg Skalicky

Rewiring commercialisation to meet the moment, with Helen Sa...

At the Informa Biotech Showcase at JPM2026, EVERSANA President Greg Skalicky and Helen Sabzevari, CEO of Precigen, discuss new commercialisation.

Sales & Marketing

Discussion in an HCP office about possibilities

HSA growth and the opportunities emerging for investors and ...

Paying attention to the intersection of public policy and business opportunity can be a winning strategy for start-ups and disrupters.

Sales & Marketing

Pharmacist with patient, explaining prescription

Why pharmacy-based engagement is pharma’s untapped adherence...

Pharma companies can work alongside pharmacists to deliver personalised outreach that informs patient treatment decisions and drives adherence.

Sales & Marketing

To reach HCPs, don’t try to be everywhere. Just be where the...

“Omnichannel” – the marketing strategy buzzword that has pervaded the space in the last several years – literally means “in every channel”; in effect, making sure a brand or message is ever

Sales & Marketing

Wooden block pyramid leading to engagement target

From omnichannel to optichannel: Redefining personalised eng...

Optichannel presents new opportunities, layering in a deep understanding of customer behaviours and preferences to enhance performance.

Sales & Marketing

Patent spelled out in wooden blocks on top of legal documents

The hidden IP problem holding innovators back

For organisations active in the US market, the impact of patent marking is financial, not administrative.

Rewiring commercialisation to meet the moment, with Helen Sa...

HSA growth and the opportunities emerging for investors and ...

Why pharmacy-based engagement is pharma’s untapped adherence...

To reach HCPs, don’t try to be everywhere. Just be where the...

From omnichannel to optichannel: Redefining personalised eng...

The hidden IP problem holding innovators back

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks